deltatrials
Completed PHASE2 NCT00165620

A Randomized, Open, Parallel, Optimal Injection Rate-Finding Study for E7337 in Dynamic CT of the Liver in Patients With Liver Disease

Sponsor: Eisai Limited

Conditions Lesion
Interventions Iomeprole
Updated 5 times since 2017 Last updated: Jan 28, 2010 Started: Nov 30, 2004 Primary completion: Apr 30, 2005

Listed as NCT00165620, this PHASE2 trial focuses on Lesion and remains completed. Sponsored by Eisai Limited, it has been updated 5 times since 2004, reflecting limited change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.

Change History

5 versions recorded

  1. Sep 2024 — Present [monthly]

    Completed PHASE2

  2. Jul 2024 — Sep 2024 [monthly]

    Completed PHASE2

  3. Jan 2021 — Jul 2024 [monthly]

    Completed PHASE2

  4. Jun 2018 — Jan 2021 [monthly]

    Completed PHASE2

  5. Jan 2017 — Jun 2018 [monthly]

    Completed PHASE2

    First recorded

Nov 2004

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:
  • Eisai Limited
Data source: Eisai Inc.

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

  • • Kumamoto, Japan
  • • Suita, Japan